Karyopharm Therapeutics | KPTI - Market Capitalization


Karyopharm Therapeutics reported $938.9M in Market Capitalization this May of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 364.22B 20.46B May/2026
Abbott USD 178.41B 39.46B Mar/2026
Amgen USD 189.89B 13.64B Mar/2026
AstraZeneca USD 301.25B 13.1B Mar/2026
BioCryst Pharmaceuticals USD 1.66B 64M Dec/2025
Bristol-Myers Squibb USD 123.83B 14.02B Mar/2026
Eli Lilly USD 869.02B 146.97B Mar/2026
Enanta Pharmaceuticals USD 122M 98M Dec/2024
GlaxoSmithKline GBP 83.8B 9.44B Mar/2026
Incyte USD 21.73B 3B May/2026
J&J USD 579.15B 78.91B Mar/2026
Karyopharm Therapeutics USD 956M 821M May/2026
MacroGenics USD 102M 4M Dec/2025
Merck USD 297.1B 35.84B Mar/2026
Nektar Therapeutics USD 15.62B 14.76B May/2026
Novartis USD 232.75B 75B May/2026
Pfizer USD 147.4B 6.42B May/2026
Regeneron Pharmaceuticals USD 81.68B 560M Mar/2026
Roche Holding CHF 266.34B 55.46B Dec/2025
Takeda JPY 8.33T 681.01B May/2026
Tectonic Therapeutic USD 390M 96M Dec/2025
TG Therapeutics USD 6.48B 1.18B May/2026
Ultragenyx Pharmaceutical USD 2.06B 1000K May/2026
Xencor USD 795M 98M May/2026